Tag: astrazeneca

PHL signs tripartite deal with UK to secure 2.6M doses of AstraZeneca vaccine

Local private firms to buy vaccines and act as donor   (Eagle News) — The Philippines has signed an agreement with the United Kingdom to secure 2.6 million doses of the COVID-19 vaccine produced by the pharmaceutical firm AstraZeneca, which will be purchased by top local businessmen for the country. The tripartite agreement was signed by national action plan against COVID=19 Secretary Carlito Galvez Jr. who is also the country’s vaccine czar, Presidential Adviser for […]

UK asks regulator to study AstraZeneca vaccine

  LONDON, United Kingdom (AFP) — The British government said on Friday it has asked its independent medicines regulator to assess AstraZeneca’s coronavirus vaccine as part of the formal approval process for the drug to be rolled out by the end of the year. More than 1.4 million people have died since the novel coronavirus emerged in China late last year, and three drug developers — Pfizer/BioNTech, Moderna and AstraZeneca/Oxford University — are currently applying […]

AstraZeneca says its vaccine needs ‘additional study’

LONDON, United Kingdom (AFP) — The head of British drug manufacturer AstraZeneca said on Thursday further research was needed on its Covid-19 vaccine after questions emerged over the protection it offers, but the additional testing is unlikely to affect regulatory approval in Europe. AstraZeneca and its partner, the University of Oxford, announced on Monday that it was seeking regulatory approval for the vaccine after it showed average 70 percent effectiveness. That rate jumped to 90 […]

AstraZeneca/Oxford say Covid vaccine shows 70% efficacy

LONDON, United Kingdom (AFP) — British drugs group AstraZeneca and the University of Oxford on Monday said their jointly-developed vaccine against Covid-19 has shown “an average efficacy of 70 percent” in trials. “This vaccine’s efficacy and safety confirm that it will be highly effective against Covid-19 and will have an immediate impact on this public health emergency,” AstraZeneca chief executive Pascal Soriot said in a statement. The results ranged between 62 and 90 percent efficacy […]

Frontrunners emerge in race for Covid-19 vaccine

PARIS, France (AFP) — Dozens of companies, from biotech start-ups to Big Pharma, are racing to develop a safe and effective Covid-19 vaccine, both to meet urgent medical need and for the potential payday. Here’s an update on the quest for a magic bullet against the coronavirus that has already killed more than a million people worldwide. How many in the pipeline? The World Health Organization (WHO) has identified 42 “candidate vaccines” at the stage […]

Vaccine still possible this year, despite trial pause: AstraZeneca

LONDON, United Kingdom (AFP) — Drugs giant AstraZeneca on Thursday said a Covid-19 vaccine could still be available by as early as the end of the year, despite a randomised clinical trial being paused. “We could still have a vaccine by the end of this year, early next year,” the UK-based company’s chief executive Pascal Soriot said in comments at a media event. AstraZeneca announced Wednesday it had “voluntarily paused” its trial of a drug […]

AstraZeneca pauses Covid-19 vaccine trial after unexplained illness

WASHINGTON, United States (AFP) — Pharmaceutical company AstraZeneca said Tuesday it had “voluntarily paused” a randomized clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness. The company, which is developing the drug alongside the University of Oxford, is a frontrunner in the global race for a Covid-19 vaccine. “As part of the ongoing randomized, controlled global trials of the Oxford coronavirus vaccine, our standard review […]

AstraZeneca starts UK covid-19 drug trial

LONDON, United Kingdom (AFP) — Pharma giant AstraZeneca said Tuesday it had begun a clinical trial of a drug designed to both prevent infection and treat people with COVID-19, with the first volunteers receiving doses. The drug, known as AZD7442, is a combination of two antibodies and is being tested on 48 healthy people aged between 18 and 55, the company said. “This trial is an important milestone in the development of our monoclonal antibody […]

AstraZeneca rejects Pfizer’s take-it-or-leave-it offer

(Reuters) – Britain’s AstraZeneca on Monday rejected a sweetened and “final” offer from Pfizer, undermining the U.S. drugmaker’s plan for a merger to create the world’s biggest pharmaceuticals group. The rebuff came nine hours after Pfizer said on Sunday it had raised its takeover offer to 55 pounds a share, or around 70 billion pounds ($118 billion) in total, and would walk away if AstraZeneca did not accept it. The rejection left some major shareholders fuming as […]